G-protein coupled receptors (GPCRs) and neurotransmitter transporters play well-established roles in the pathophysiology of depression and are targets for present antidepressant drugs, and are also recognized targets in the search for more specific and effective pharmacological approaches. This evidence concerns the gene SLC6A2 and major depressive disorder.